IDH1 and glioblastoma: IDH1-mutated U87MG glioblastoma cells showed a marked decrease in the mitochondrial membrane potential when subjected to treatment with increasing concentrations of ABT263 when compared to U87MG IDH1-WT cells (Fig. 2f).